BACKGROUND: The cell functions involved in the action of insulin Ð receptor binding, enzyme and transporter activities Ð are controlled by membrane properties. We have previously shown that the fasting plasma insulin (FPI) concentration and the homeostasis model assessment (HOMA) estimate of insulin resistance are associated with the sphingomyelin concentration in the erythrocyte membranes of obese women. OBJECTIVES: (1) To study the distribution of phospholipid classes in the plasma membrane and their association with insulin resistance markers in the adipocyte, an insulin-sensitive cell in obese women. (2) To investigate the in¯uence of diabetes in a small group of obese women treated by diet alone. (3) To compare the distribution of phospholipids in erythrocyte membranes in a subgroup of obese nondiabetic and diabetic women. SUBJECTS: Subcutaneous fat biopsies were taken from the abdominal region of 19 obese non-diabetic and seven obese type 2 diabetic women. Erythrocyte membrane assessment was performed in a subgroup of 10 of the 19 obese nondiabetic and in the seven diabetic patients. METHODS: The phospholipid composition of adipocyte and erythrocyte plasma membranes was analyzed by high performance liquid chromatography. RESULTS: FPI was positively correlated with the adipocyte membrane contents of sphingomyelin (P`0.001), phosphatidylethanolamine (P`0.05), and phosphatidylcholine (P`0.01) in the obese nondiabetic women. Similar correlations were obtained with HOMA. A stepwise multiple regression analysis indicated that sphingomyelin accounted for 45.6 and 43.8% of the variance in FPI and HOMA values as an independent predictor. There was a similar positive independent association between FPI and SM in the erythrocyte membranes of the studied subgroup. Diabetes per se did not in¯uence the independent association between SM membrane contents and FPI in both cell types. CONCLUSION: These results suggest a link between membrane phospholipid composition, especially SM, and hyperinsulinemia in obese women. International Journal of Obesity (2000) 24, 1600±1607 Keywords: obesity; type 2 diabetes; hyperinsulinemia; adipocyte; erythrocyte; plasma membrane; phospholipid classes
Introduction
Low insulin sensitivity is common in obese individuals and is primarily due to defects in the pathway of insulin action in target tissues: muscle, liver and adipose tissue. It has been suggested recently that insulin resistance is associated with alterations in cell membrane properties. 1, 2 Recent studies have demonstrated relationships between the fatty acid composition of phospholipids in skeletal muscle and the action of insulin. 3 ± 8 We have previously shown that changes in the distribution of phospholipid classes of the erythrocyte membrane were also associated with fasting plasma insulin (FPI) concentration and the homeostasis model assessment (HOMA) estimate of insulin resistance in 69 obese nondiabetic normoglycemic women. The most insulin resistant patients had the highest erythrocyte membrane sphingomyelin content. 9 These results suggest that the membrane phospholipids play a role in insulin sensitivity. However, these erythrocytes are not sensitive to insulin, although there are insulin receptors on their surface. We have therefore investigated the relationship between membrane phospholipid composition and markers of insulin resistance in an insulin-sensitive tissue. The role of adipose tissue in resistance to insulin has been recently underlined. 10 According to Bjo Èrntorp, 11 insulin resistance may originate in adipose tissue and be followed by an increased ef¯ux of free fatty acids, with secondary effects causing or increasing insulin resistance in muscle and liver tissue. To the best of our knowledge, the distribution of phospholipid classes in the human adipocyte membrane has not been explored. One aim of the study was therefore to investigate the relationship between the phospholipid composition of adipocyte plasma membranes and markers of insulin resistance in obese nondiabetic women. The second aim of the study was to verify the results in a group of obese diabetic women. Finally, the data on adipocytes and erythrocytes from each member of a subgroup of obese women were compared.
Subjects and methods

Subjects
We determined the phospholipid composition of adipocyte membranes taken from obese Caucasian women with a body mass index (BMI) b 27 kgam 2 : 19 nondiabetic women and seven diabetic women with recent onset of type 2 diabetes. Erythrocyte membranes studies were carried out in a subgroup of 10 of the 19 obese nondiabetic women and in the seven obese diabetic women. Their body weights were stable at the time of the study. No patient had been involved in a weight reduction programme over the previous 3 months. The glucose tolerance, based on the oral glucose tolerance test (OGTT) was normal according to WHO criteria 12 in the nondiabetic patients. The diabetes was well controlled (HbA1c, 6.5 ± 8%). None of the subjects had any signs of cardiovascular disease, primary dyslipidemia or other chronic diseases. Hypertriglyceridemia was considered to be a triglyceride concentration greater than 2.82 mmolal (250 mgadl), and hypercholesterolemia was considered to be a cholesterol concentration greater than 5.2 mmolal (200 mgadl). No subject was treated with any drug that could in¯uence the plasma lipid concentrations or glucose tolerance. Written informed consent was obtained from all subjects and the study was approved by the Ethics Committee of the Nancy University Hospital.
Clinical studies
Anthropometric measurements. Body weight was measured to the nearest 0.1 kg on a precision digital scale. Standing height was measured to the nearest 0.1 cm without shoes on a stadiometer. BMI was calculated as weight in kilograms divided by height in meters squared (kgam 2 ). Waist circumference was measured at the midpoint between the lower border of the rib cage and the iliac crest and the hip circumference at the maximum circumference at the level of the femoral trochanters. The waist-to-hip ratio (WHR) was used as a measure of upper-body adiposity.
Adipose tissue biopsies. An incisional biopsy was performed under local anesthesia from the lower abdominal wall and subcutaneous fat tissue (5 ± 10 g) was obtained. Adipose tissue was frozen in liquid nitrogen immediately after biopsy and stored at 780 C.
Biochemical determinations. Blood samples were taken from an antecubital vein in the morning after a 12 h overnight fast. Fasting plasma glucose was measured by the glucose oxidase method with a Beckman BGA II Glucose Analyzer (Beckman Instruments Inc., Fullerton, CA, USA). HbA1c was measured by high-performance liquid chromatography with an ion exchange column (Bio-Rad, Paris, France). Plasma triglycerides and cholesterol were measured enzymatically (kits from Boehringer, Mannheim, Germany). High-density lipoprotein cholesterol (HDL cholesterol) in the plasma was determined after precipitation of very-low-density and low-density lipoproteins with phosphotungstic acid. Low-density lipoprotein cholesterol (LDL cholesterol) was estimated using Friedewald's formula. Plasma insulin was measured by radioimmunoassay (CIS Biointernational, ORIS group, Gif-sur-Yvette, France). The sensitivity of the radioimmunoassay was 7 pmolal, and the intra-and interassay coef®-cients of variation were 8.2% and 8.8%, respectively. The cross-reactivity with proinsulin was 14%. Fasting plasma insulin and homeostasis model assessment (HOMA) were chosen as markers of insulin resistance. The HOMA estimate of insulin resistance was assessed by the formula: (fasting insulin (mUal) Â fasting glucose (mmolal))a22.5. 13 
Membrane studies
Adipocyte plasma membrane isolation. Ten milliliters of a HEPES-sucrose buffer (buffer 1): 20 mmolal HEPES, 255 mmolal sucrose, 1 mmolal EDTA, pH 7.4 containing protease inhibitors (5 mgaml leupeptin, 5 mgaml pepstatin, and 5 mgaml aprotinin) was added to adipose tissue and the tissue homogenized at 4 C in an Ultra-Turrax (TP18) homogenizer. The homogenate was ®rst centrifuged at 500 g for 10 min at 4 C. The supernatant was separated from the pellet and fat cake, and then centrifuged at 150,000 g for 2 h at 4 C. The pellet (total membrane fraction) was suspended in buffer 1 and layered carefully onto a sucrose cushion (41% in buffer 1), which was then centrifuged for 1 h at 95,000 g. The plasma membrane fraction that settled at the interface, was collected, diluted in buffer 1 and washed by centrifugation at 200,000 g for 20 min at 4 C. The resulting pellet was suspended in Tris ± EDTA buffer (buffer 2): 1 mmolal Tris, 1 mmolal EDTA, 10 mmolal NaCl, and the protein content was estimated by the Lowry method. The Hyperinsulinemia, adipocyte and erythrocyte phospholipids N Zeghari et al membrane suspensions were stored at 780 C until further analysis.
Erythrocyte membrane isolation. Venous blood samples were collected over EDTA (1 mgaml) from fasting subjects. Erythrocyte membranes were prepared as described previously. 9 Membrane phospholipid determination. Lipids were extracted from adipocyte or erythrocyte membranes with methanol and chloroform 14 containing 50 mgal 2,6-di-butyl-P-cresol to prevent lipid peroxidation. The organic phase was evaporated to dryness under a stream of nitrogen at room temperature and the lipid residue was dissolved in chloroform. Its components were separated by HPLC. 15 Lysophosphatidylcholine (10 mga100 mg protein) was added as internal standard before extraction. Phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS) and sphingomyelin (SM) were detected with a light scattering evaporative detector. Phospholipid data are expressed as a weight concentration calculated from calibration curves established for each phospholipid. There is evidence that results expressed as concentrations and those calculated on a percentage weight may lead to different conclusions, 16 and that concentrations are more accurate re¯ections of changes than are percentage weight calculations. 17 
Statistical analysis
Values are meansAE standard error of the mean (s.e.m.), or medians with 25th and 75th percentiles. Variables were assessed for normality by the skewness and kurtosis test. The variables which were not normally distributed were logarithmically transformed for statistical analysis. Groups were compared using Student's t-test for parametric data and the Mann ± Whitney test for non-parametric data. Pearson correlation coef®cients were derived to show the relationship between variables (log transformed when necessary) strati®ed by glucose category (obese nondiabetic and obese diabetic subjects). Multivariate correlations were analyzed by stepwise regression analysis and multiple regression analysis to explain fasting insulin concentration or HOMA value. P`0.05 was used to de®ne statistical signi®cance. All calculations were performed using Statview software (Abacus Concepts, Berkeley, CA, USA).
Results
The relevant clinical and metabolic characteristics of the obese nondiabetic and type 2 diabetic subjects are shown in Table 1 . ). Two diabetic women had morbid obesity.
FPI concentrations were positively correlated with WHR (r 0.532, P`0.01), and negatively with HDL cholesterol (r 7 0.521, P`0.05) in the obese nondiabetic women. Nearly identical results were obtained with the HOMA estimate of insulin resistance (data not shown).
Adipocyte membrane studies
Phosphatidylcholine and PE were the major phospholipids, while SM, PS and PI were minor components in both groups ( Table 2 ). The obese diabetic women had signi®cantly higher PE (P`0.05) and lower PS (P`0.05) membrane contents. The total phospholipids of the adipocyte membranes from the obese LDL: low-density lipoprotein. P-values: *P`0.05; **P`0.005; ***P`0.0001, compared to the obese nondiabetic group. Table 3 shows the Pearson correlation coef®cients between FPI and membrane concentrations of phospholipid classes. The fasting plasma insulin concentration was positively correlated with plasma membrane SM (P`0.001) (Figure 1 ), PC (P`0.01) and PE content (P`0.05) in the obese nondiabetic women. The fasting plasma insulin were positively correlated with SM (P`0.05) and PC (P`0.05) contents in the obese type 2 diabetic women. Similar correlations were obtained with HOMA.
Stepwise multiple regression analyses were performed to determine the independent predictors of FPI or HOMA values in the group of obese nondiabetic women. Forward and backward analyses produced similar results. In models including BMI or WHR, plasma lipid parameters, membrane phospholipid concentrations as the independent variables, SM correlated most strongly with fasting insulin concentration or HOMA values, displacing all other predictor variables from the model: 45.6 and 43.8% of the variance in FPI and HOMA value, respectively were explained by SM (Table 4 ). Even after controlling for BMI and WHR, SM was still signi®cantly predictive of insulin resistance indexes.
The in¯uence of diabetes was studied in the whole group due to the few diabetic women. The diabetes category (or plasma glucose level), age and BMI were introduced in a multiple regression analysis with FPI as the dependent variable. SM was the only explanatory independent variable of FPI (t 3.72, P`0.005). However, multivariate analysis revealed that diabetes was also associated with the HOMA estimate of insulin resistance (t 2.93, P`0.01), independently of SM, but the strong association between SM and HOMA persisted (t 3.49, P`0.005).
Erythrocyte membrane studies
We also analyzed the phospholipids in the erythrocyte of a subgroup (n 10) of the 19 studied obese nondiabetic women and from the seven obese type 2 diabetic women to determine whether the variations in the SM content of the erythrocyte membranes could re¯ect those in the adipocyte membranes.
The total phospholipids as well as the different phospholipid classes of the erythrocyte membranes from the two groups did not differ signi®cantly. In the obese diabetic women, the fasting plasma insulin concentration was positively correlated with the SM content of the erythrocyte membrane (r 0.964, P`0.005) but not with the other phospholipids. The same tendency was observed in the obese nondiabetic women, but this did not reach statistical signi®cance. A multiple linear regression analysis was performed on the two groups taken together using FPI as the dependent variable and membrane SM, BMI, age, plasma glucose concentration or the category (obese P-values, *P`0.05; **P`0.01; ***P`0.001. Figure 1 Relationship between fasting plasma insulin concentration and the sphingomyelin content in adipocyte plasma membranes of obese non diabetic women. r 0.676, P`0.001. The SM content of the adipocyte membrane was positively correlated with the SM content of the erythrocyte membrane (r 0.542, P`0.05) for the whole subgroup of 10 obese nondiabetic women and seven obese diabetic women. When these subjects were grouped in tertiles according to fasting plasma insulin, there was a regular increase in the SM contents of the erythrocyte and adipocyte membranes from the ®rst to the third tertile (Figure 2) . The ANOVA between the three tertiles indicated that the differences between the three groups were signi®cant for the SM membrane content of adipocytes (F 7.15, P`0.01) and close to the signi®cance for the erythrocytes (F 2.48, P 0.11). Subjects of the highest tertile in fasting plasma insulin had higher SM content in adipocytes than those of the lowest tertile (P`0.01), but the differences did not reach statistical signi®cance (P 0.08) for the erythrocytes.
Discussion
We measured the phospholipid composition of adipocyte plasma membranes in a group of 19 obese patients and found a strong association between the fasting insulin concentration or HOMA estimate of insulin resistance and the classes of adipocyte membrane phospholipids. The multivariate analysis shows that the adipocyte membrane sphingomyelin content is the major independent predictor of insulin resistance markers in obese nondiabetic women. The patients studied were normoglycemic and normolipidemic to eliminate any possible interference of diabetes and dyslipidemia with the relationships between insulin resistance and membrane composition.
The main phospholipids are phosphatidylcholine and phosphatidylethanolamine, with sphingomyelin, phosphatidylserine and phosphatidylinositol being less abundant. This phospholipid pro®le is compatible with data for rat adipocytes. 18 The mean values of total phospholipidsaprotein (1.16 AE 0.10) and phosphatidylcholineaprotein (0.53 AE 0.06) mass ratios are close to those reported for the adipocyte plasma membranes of massively obese patients. 19 The total phospholipid (PL) content and each class of phospholipids in the adipocyte membrane varied greatly between individuals. The signi®cance of these inter individual variations is unclear, but it seems unlikely that they are due to the methods used, such as protein adsorption to the membrane fraction during separation. If this were so, some samples of adipocyte membranes should have contained relatively little of each class of phospholipids, while others should have had higher concentrations. But instead, the correlation coef®cients for the relationships with fasting plasma insulin showed that the adipocyte samples having the highest PC, PE and SM contents did not have the highest PI and PS contents.
The total PL content is signi®cantly positively correlated with WHR, fasting plasma insulin and HOMA value. Adipocyte hypertrophy occurs in obese patients. 20 There are also correlations between fat cell size and plasma insulin in non-obese subjects and obese adults. 21, 22 Therefore, the increased fat cell surface area in obesity andaor insulin resistance may require more phospholipids. It has been shown that the metabolic responsiveness of adipocytes is linked to the cell size in both animal and human adipose tissue: the basal and insulin-stimulated glucose transport rates are decreased in large adipocytes and can be related to depleted numbers of GLUT 4 glucose transporters and GLUT 4 decreased mRNA concentration with increasing adiposity. 23 Therefore it is possible that the increased PL of the adipocyte membrane re¯ects in part the increased adipocyte size, but even so, the preferential increase in SM or other changes in membrane composition may be responsible for an altered insulin action. We determined the mean diameter of adipocytes from six subjects within the group of 19 obese nondiabetic subjects, but found no signi®cant relationship between the cell surface area and total PL contents, or with the SM content. However, this was done only in very obese patients.
Con®rmation of the results was obtained in the erythrocyte, a cell that does not change size greatly with insulin resistance. In the obese diabetic group, there is a positive relationship between the erythrocyte SM concentration and insulin concentration. For obese subjects without diabetes, the direction of the correlation is the same, but is not statistically signi®-cant, which may be attributed to the small number of Figure 2 Mean sphingomyelin content (mgamg protein) in adipocyte and erythrocyte membranes. Ten of the 19 nondiabetic and the seven diabetic women who had phospholipid determinations in both adipocyte and erythrocyte membranes were grouped in tertiles according to the fasting plasma insulin concentration. Mean FPI AE s.e.m.: ®rst tertile, 12.8 AE 1.8 mUal; second tertile, 19.5 AE 0.7 mUal; third tertile, 34.4 AE 4.8 mUal.
Hyperinsulinemia, adipocyte and erythrocyte phospholipids N Zeghari et al subjects in this group. It was for this reason that we performed multivariate analyses on the whole study population. BMI, age, plasma glucose concentration or group category were entered into the fasting insulin model. There was a positive independent association between erythocyte SM and fasting insulin or HOMA value. When the effect of other covariates was taken into account the association remains strong. These ®ndings, together with our previous data in obese women with normal glucose tolerance, 9 suggest that membrane SM concentration is an important predictor of hyperinsulinemia or insulin resistance in obese women.
Phospholipid composition was assessed in both adipose tissue biopsies and erythocytes of 10 of the 19 obese non diabetic women and the seven obese diabetic women, thus allowing data on erythrocytes and adipocytes from the same subjects to be compared. The ®nding that there was the same association between SM and fasting insulin or HOMA value in adipocyte and in erythrocyte membranes points to a change in SM in insulin resistance states, even if the PL subclass pro®le was not exactly the same in both cell types.
The relationships between insulin resistance and variations in adipocyte phospholipids could be overestimated because populations studied have included some massively obese patients. An increased fasting insulin level usually closely parallels an increased BMI. However, two of the ®ve massively obese nondiabetic women had rather low fasting insulin concentrations and HOMA values. There was also only a weak nonsigni®cant correlation between SM and BMI (r 0.262, P 0.278) in the obese nondiabetic group.
The data show that diabetes per se is not independently associated with insulin in multivariate models. The membrane content of SM is a signi®cant predictor of fasting plasma insulin or HOMA value when plasma glucose or diabetes is introduced into the model. Further studies are now needed to compare SM in a greater number of individuals with impaired glucose tolerance and in diabetic subjects with fair or poor blood glucose control.
There may be several links between an increase in membrane SM content and impaired insulin action. Studies in arti®cial membranes support this assumption. 24, 25 An enrichment in SM inhibits the tyrosine kinase activity in rat liver plasma membranes, 26 decreases the phosphatidylinositol phosphodiesterase activity activated by diacylglycerol 27 and glucose transport in phospholipid vesicles. 25 These effects of SM are probably due in part to the ability of this phospholipid to stabilize a bilayer structure and to increase membrane rigidity. Our previous observations 9 that a high erythrocyte membrane SM content is correlated with insulin resistance and with low erythrocyte membrane¯uidity are consistent with this.
SM metabolites may also be involved via several cytokines. The expression of tumor necrosis factor-a (TNF-a) in subcutaneous adipose tissue is increased with obesity, suggesting that an overproduction of TNF-a by adipose tissue is involved in the obesityassociated insulin resistance. 28, 29 There is evidence that TNF-a affects insulin transduction via the sphingomyelin pathway. This pathway is initiated by the hydrolysis of plasma membrane sphingomyelin, which generates ceramide. Ceramide mediates the downregulation of glucose transporter (GLUT4) mRNA 30 by TNF-a and the decrease in GLUT4 translocation in 3T3-L1 adipocytes. 31, 32 Recent data also implicate ceramide in the impaired tyrosine phosphorylation of the IRS-1. 33 Although phosphatidylethanolamine (PE) and phosphatidylcholine (PC) have not been included in the multivariable model (in adipocyte or in erythrocyte), their role cannot be ruled out. The adipocyte membrane PE content is also strongly correlated with markers of insulin resistance and may be an important regulator of insulin action. A high membrane PE content leading to an increase in the head group spacing of phospholipids in lipid bilayers of de®ned composition is closely correlated with decreased protein kinase C activity, a key enzyme in insulin action. 34 Moreover, PE could affect the activity of the hormone-sensitive lipase (HSL). Although the subcellular location of HSL is not clearly de®ned, it is associated with membrane fractions 35 and PE has been reported to selectively stimulate the HSL activity of adipose tissue. 36 The increased free fatty acids resulting from the acute hydrolysis of endogenous triacylglycerol also reduce insulin-stimulated glucose uptake. 37 The adipocyte phosphatidylcholine (PC) content is also correlated with the fasting plasma insulin and HOMA values, but the possible links between PC and insulin are not clear. It has been reported that insulin stimulates the synthesis of phospholipids, particularly PC, via the CDP-choline pathway. 38 Insulin also stimulates the methylation of endogeneous PE, resulting in an increased PC concentration in rat adipocyte plasma membranes. 39 Several studies have found strong correlations between the phospholipid fatty acid composition of skeletal muscle and estimates of insulin resistance. 3 ± 8 Our present results, as well as our previous data, 9 suggest that the distribution of phospholipid classes in the adipocyte membrane is also associated with insulin resistance. However, it is not clear whether insulin resistance is the cause or the consequence of the changes in the phospholipid contents of the adipocyte membrane. These changes could be caused by the dyslipidemia associated with insulin resistance, although the exact molecular defects linking insulin resistance and dyslipidemia are still unclear. 40 Changes in lipoprotein composition 41 can modify the exchange of cholesterol and phospholipids between lipoproteins, or between lipoproteins and cells and in¯uence the composition of plasma membranes. These changes could be mediated by cholesteryl Hyperinsulinemia, adipocyte and erythrocyte phospholipids N Zeghari et al ester transfer protein (CETP), which has a role in the selective uptake of HDL cholesteryl esters by human adipocytes, 42 or by phospholipid transfer protein (PLTP). 43 CETP and PLTP activities are elevated in obesity 44 and in insulin resistance 45 as well as the HDL binding to adipocytes. 19 The hormone status may be also important. PE synthesis is affected by testosterone 46 and SM synthesis by dexamethasone. 47 Finally, factors such as the diet must also be taken into consideration. It has been suggested that the amount of dietary fat as well as the nature of fatty acids regulate various steps in the biosynthesis of membrane phospholipids. Total PL, PC, PE and SM in rats fed a diet high in saturated fat were 1.7, 1.5, 2 and 5-fold respectively higher than in rats on an unsaturated, high fat diet. 16 Dietary ®sh and sun¯ower oil modify the lipid structure of rat 48 and pig 49 adipocyte plasma membranes by changing the ratio of PC to SM.
In conclusion, these data on adipocytes and erythrocytes and those of a previous study on erythrocytes 9 strongly suggest that changes in the phospholipid composition of the plasma membrane, especially in SM, are linked to insulin resistance andaor hyperinsulinemia in obese patients. The membrane phospholipid pro®le could be important in the various disorders associated with insulin resistance, particularly accelerated atherosclerosis and metabolic syndrome X, but the mechanisms responsible for changes in membrane phospholipid composition are still poorly understood. We are presently investigating the relationships between HDL composition, PLTP activity and concentration, and the phospholipid composition of adipocyte membranes in vivo and in vitro using adipocyte cell lines.
